Health

Bio-IT World Conference & Expo to Bring Together Top Biopharma Executives for its Hybrid Return

Leave a comment


Bio-IT World Conference & Expo, September 20-22, 2021

We are excited to see you at our new venue in Boston and look forward to hearing the latest research, science, and solutions


NEEDHAM, Mass. (PRWEB)

Bio-IT World Conference & Expo has just released the final agenda for the 20th anniversary event—taking place virtually and in-person on September 20-22, 2021 in Boston, Mass.—featuring a comprehensive list of 180+ biopharma executives along with other industry experts.

Bio-IT World Conference & Expo will return this year to Boston, Mass., once again bringing a diverse lineup of speakers and an expo with leading solution providers to its new venue, the Sheraton Boston. The hybrid format also features a virtual platform that provides an option for biopharma leaders from around the world to engage with their peers and expert thought leaders safely and conveniently.

“Bio-IT World continues taking a leadership role to keep our life science community connected. We are investing in technology to ensure you stay connected with others whether you attend in-person or virtually. We are grateful for the support of our community during the past year as we pivoted from an in-person meeting in 2019, to a 100% virtual meeting in 2020, and now to a hybrid format for 2021. We are excited to see you at our new venue in Boston and look forward to hearing the latest research, science, and solutions,” said Bio-IT World Executive Event Director, Cindy Crowninshield.

Biopharma executives who will be sharing their thought leadership this September include:

  • Ahsan Huda, PhD, Senior Director, Data Science, Pfizer. Inc.

  • Alan Andryc, Associate Director, Observational Health Data Analytics, Janssen Pharmaceuticals. Inc.

  • Alan Rogerson, Principal Scientist, Research and Early Development Informatics, Roche Products Ltd.

  • Albert Wang, MS, Senior Director, IT for Translational Medicine & Informatics & Predictive Sciences, Bristol-Myers Squibb

  • Aleksandar Stojmirovic PhD, Associate Scientific Director, Data Science, Janssen Research & Development, LLC

  • Alex Weigel, PhD, Head of Scientific Solution Engineering & Architecture, Roche

  • Anastasia Christianson, Vice President, R&D Business Technology, Janssen Pharmaceuticals

  • Andreas Steinbacher, PhD, Lead Discovery Informatics Data Management, Roche pRED Informatics

  • Bethany F Hyde, Data Scientist, Data Sciences, Janssen Pharmaceuticals, Inc.

  • Bing-Yuan Chen, PhD, Lead Informatics Analyst, DevSci Informatics, Genentech, Inc.

  • Bryn Roberts, PhD, Senior Vice President & Global Head of Data Services, Roche

  • Celine Han, Senior Scientist & Computational Biologist, Bristol Myers Squibb

  • Christian Blumenroehr, PhD, Principal Scientist, Research Informatics, Roche pRED

  • Christophe Chabbert, PhD, Senior Scientist, Data Integration and ML Ops, Roche

  • Clair Blacketer, Associate Director, Janssen

  • Daniel Butnaru, PhD, Research Architect, Roche Diagnostics GmbH

  • David Herzig, Senior Scientist, Roche Pharma

  • Erik Koenig, Director, Insights and Analytics, Takeda Data Sciences Institute, Takeda Pharmaceuticals

  • Felipe Albrecht, PhD, Senior Scientist, Pharma Research and Early Development Informatics, Roche

  • Gerard Randolph, Project Leader, Pharma Research & Early Development Informatics, Roche

  • Govinda R Bhisetti, PhD, Principal Investigator & Head, Computational Chemistry, Biogen

  • Helen Li, Head, IT, Lilly Biotechnology Center, Eli Lilly & Co.

  • Holly Soares, PhD, Vice President & Head, Precision Medicine, Pfizer Inc.

  • Jay Bergeron, Director, Translational Research Business Technologies, Pfizer

  • Jay Randazzo, Digital Service Owner, Large Molecule Research, Sanofi

  • Jenny Ghith, Global Scientific Publications and Innovations Director, Pfizer Oncology, Pfizer

  • Joerg Degen, PhD, Global Head, Early Development Informatics, Roche Pharma

  • John Boles, Business Technology Leader, Janssen Biotherapeutics

  • Jordan Brayanov, PhD, Lead, R&D Digital Strategy, Takeda Pharmaceutical Co. Ltd.

  • Ketan Paranjape, Vice President, Commercial Business Operations, Roche Diagnostics

  • Krista McKee, Head, Insights & Analytics, Takeda R&D Data Sciences Institute, Takeda Pharmaceuticals

  • Lihua Yu, PhD, President and Chief Data Science Officer, H3 Biomedicine, Inc.

  • Lijuan Li, Senior Staff Engineer (CMC) in Process Modeling, Process Strategy and Development Support, Takeda

  • Magdalena Wienken, PhD, Strategy Manager, Digital Tissue Diagnostic, AstraZeneca GmbH

  • Meghan Raman, Director, IT – Biometrics & Data Sciences, Bristol-Myers Squibb Co.

  • Monica Wang, PhD, Principal Technology Lead, Scientific Informatics, Takeda

  • Pablo Cingolani, PhD, Principal Scientist, Next Generation Sequencing & AI, AstraZeneca

  • Pedro Ivo Guimaraes, PhD, Scientist and Product Manager, Roche

  • Philip Ross, PhD, Director, Clinical Data Utilization, Knowledge Science Research, Bristol-Myers Squibb

  • Prasanna Rao, Head, AI & Data Science, Data Monitoring and Management, Clinical Sciences and Operations, Global Product Development, Pfizer Inc.

  • Quan Yang, PhD, Executive Director Research & Pre-clinical Development IT, Information Systems & Technology, Regeneron Pharmaceuticals

  • Raj Nimmagadda, Global Head, R&D Data Office, R&D Digital and Data Sciences, Sanofi US

  • Ramesh V. Durvasula, PhD, Vice President & Information Officer, Research Labs, Eli Lilly & Co.

  • Richard Bishop, Executive Director, Research & Early Delivery (R&ED) Digital Delivery, Bristol Myers Squibb

  • Robert Hayden, Enterprise Architect, Amgen

  • Sabine Schefzick Jalaie, PhD, Director Advanced Analytics Platform, Science & Clinical Analytics & Analytic Innovation, Pfizer Inc.

  • Santha Ramakrishnan, PhD, Global Data Governance Lead, Sanofi

  • Sebastian Scharf, PhD, Data Scientist, Roche Pharma

  • Srikanth Ramakrishnan, Director, Intelligent Automation & Analytics, Janssen Pharmaceuticals R&D IT

  • Srinivasan Sadanandhamurthy, Director IT Digital and Data Engineering, Information Systems & Technology, Regeneron Pharmaceuticals

  • Timothy J. Schultz, PhD, Principal Scientist, Data Science, Janssen Pharmaceuticals, Inc.

  • Tom Defay, Deputy Head, Diagnostic Strategy and Development, Alexion Pharmaceuticals

  • Tom Plasterer, PhD, Director, Bioinformatics, Data Science & AI, Biopharmaceutical R&D, AstraZeneca

  • Vikas Patel, Executive Director, IT Engineering, Research Labs, Merck & Co.

  • Weiwei Schultz, PhD, Senior Data Scientist, Immunology Biomarker, Janssen R&D LLC

  • Xiong Sean Liu, PhD, Director, Data Science & Artificial Intelligence, Novartis

  • Ye Jin Jenna Eun, PhD, Principal Data Scientist, Commercial Data Science, Johnson & Johnson Pharmaceutical R&D

Attend Bio-IT World Conference & Expo this September 20-22, 2021, at the Sheraton Boston in Boston, Mass. In-person space is limited this year. Register today to secure your spot: bio-itworldexpo.com.

About Bio-IT World Conference & Expo

For 20 years, the Bio-IT World Conference & Expo has been the world’s premier event showcasing technologies and analytic approaches that solve problems, accelerate science, and drive the future of precision medicine. Bio-IT World unites a community of leading life sciences, pharmaceutical, clinical, healthcare, informatics and technology experts in the field of biomedical research, drug discovery & development, and healthcare from around the world.

For sponsorship opportunities contact Angela Parsons, VP, Business Development at aparsons@healthtech.com.

To register to attend Bio-IT World Conference & Expo, click here.

About Cambridge Healthtech Institute

Cambridge Healthtech Institute (CHI), a division of Cambridge Innovation Institute, is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, CROs, academia, and niche service providers. CHI is renowned for its vast conference portfolio held worldwide including PepTalk, Molecular Medicine Tri-Conference, SCOPE Summit, Bio-IT World Conference & Expo, PEGS Summit, Drug Discovery Chemistry, World Pharma Week, The Bioprocessing Summit, Next Generation Dx Summit, Immuno-Oncology Summit, and Discovery on Target. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Bio-IT World, Clinical Research News and Diagnostics World. For more information visit healthtech.com.

Share article on social media or email:

Leave a Reply